156 related articles for article (PubMed ID: 37386304)
21. Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastases: reappraisal in the era of modern chemotherapy.
Tranchart H; Chirica M; Faron M; Balladur P; Lefevre LB; Svrcek M; de Gramont A; Tiret E; Paye F
World J Surg; 2013 Nov; 37(11):2647-54. PubMed ID: 23982776
[TBL] [Abstract][Full Text] [Related]
22. The Prognostic Value of Total Tumor Volume Response Compared With RECIST1.1 in Patients With Initially Unresectable Colorectal Liver Metastases Undergoing Systemic Treatment.
Wesdorp NJ; Bolhuis K; Roor J; van Waesberghe JTM; van Dieren S; van Amerongen MJ; Chapelle T; Dejong CHC; Engelbrecht MRW; Gerhards MF; Grunhagen D; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Liem MSL; van Lienden KP; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Swijnenburg RJ; Punt CJA; Huiskens J; Kazemier G
Ann Surg Open; 2021 Dec; 2(4):e103. PubMed ID: 37637880
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis.
Araujo RL; Gönen M; Herman P
Ann Surg Oncol; 2015 Sep; 22(9):3070-8. PubMed ID: 25586244
[TBL] [Abstract][Full Text] [Related]
24. Sub-millimeter surgical margin is acceptable in patients with good tumor biology after liver resection for colorectal liver metastases.
Xu D; Wang HW; Yan XL; Li J; Wang K; Xing BC
Eur J Surg Oncol; 2019 Sep; 45(9):1551-1558. PubMed ID: 30879931
[TBL] [Abstract][Full Text] [Related]
25. [Preoperative chemotherapy in the surgical treatment of colorectal liver metastases].
Dede K; Láng I; Pörneczi B; Mester G; Fekete A; Kőszegi G; Mersich T; Besznyák I; Bursics A
Magy Seb; 2013 Dec; 66(6):325-30. PubMed ID: 24333977
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab.
Sasaki K; Margonis GA; Andreatos N; Wilson A; Weiss M; Wolfgang C; Sergentanis TN; Polychronidis G; He J; Pawlik TM
Br J Surg; 2017 Jun; 104(7):926-935. PubMed ID: 28266705
[TBL] [Abstract][Full Text] [Related]
27. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI
Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686
[TBL] [Abstract][Full Text] [Related]
28. Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastases.
Ruzzenente A; Bagante F; Ratti F; Beal EW; Alexandrescu S; Merath K; Makris EA; Poultsides GA; Margonis GA; Weiss MJ; Popescu I; Aldrighetti L; Guglielmi A; Pawlik TM
HPB (Oxford); 2019 Sep; 21(9):1230-1239. PubMed ID: 30792047
[TBL] [Abstract][Full Text] [Related]
29. Hepatic vascular inflow occlusion is associated with reduced disease free survival following resection of colorectal liver metastases.
Olthof PB; Huiskens J; Schulte NR; Wicherts DA; Besselink MG; Busch OR; Tanis PJ; van Gulik TM
Eur J Surg Oncol; 2017 Jan; 43(1):100-106. PubMed ID: 27692534
[TBL] [Abstract][Full Text] [Related]
30. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
[TBL] [Abstract][Full Text] [Related]
31. The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival.
Höppener DJ; Nierop PMH; van Amerongen MJ; Olthof PB; Galjart B; van Gulik TM; de Wilt JHW; Grünhagen DJ; Rahbari NN; Verhoef C
Ann Surg Oncol; 2019 Sep; 26(9):2812-2820. PubMed ID: 31147988
[TBL] [Abstract][Full Text] [Related]
32. Multivisceral Resection for Locally Invasive Colorectal Liver Metastases: Outcomes of a Matched Cohort Analysis.
Hand F; Sanabria Mateos R; Durand M; Fennelly D; McDermott R; Maguire D; Geoghegan J; Winter D; Hoti E
Dig Surg; 2018; 35(6):514-519. PubMed ID: 29346790
[TBL] [Abstract][Full Text] [Related]
33. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
Pak LM; Kemeny NE; Capanu M; Chou JF; Boucher T; Cercek A; Balachandran VP; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; D'Angelica MI
J Surg Oncol; 2018 Mar; 117(4):634-643. PubMed ID: 29165816
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of infracentimetric colorectal liver metastases.
Frosio F; Cervantes B; Nassar A; Faermark N; Sanou Y; Bonnet S; Lefevre M; Louvet C; Gayet B; Fuks D
Langenbecks Arch Surg; 2022 Aug; 407(5):1971-1980. PubMed ID: 35347398
[TBL] [Abstract][Full Text] [Related]
35. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.
Galjart B; Nierop PMH; van der Stok EP; van den Braak RRJC; Höppener DJ; Daelemans S; Dirix LY; Verhoef C; Vermeulen PB; Grünhagen DJ
Angiogenesis; 2019 May; 22(2):355-368. PubMed ID: 30637550
[TBL] [Abstract][Full Text] [Related]
36. Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.
Simpson AL; Doussot A; Creasy JM; Adams LB; Allen PJ; DeMatteo RP; Gönen M; Kemeny NE; Kingham TP; Shia J; Jarnagin WR; Do RKG; D'Angelica MI
Ann Surg Oncol; 2017 Sep; 24(9):2482-2490. PubMed ID: 28560599
[TBL] [Abstract][Full Text] [Related]
37. Analysis of survival and clinicopathological characteristics in patients after liver resection for colorectal liver metastases according to resection margin.
Casas-Sicilia E; Jiménez-Bernadó A; Jaime-Sánchez A; Gracia-Solanas JA; Palacios-Gasos P; Borrego-Estella VM
Cir Cir; 2022; 90(S1):96-107. PubMed ID: 35944108
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
[TBL] [Abstract][Full Text] [Related]
39. Survival benefit of neoadjuvant chemotherapy and surgery versus surgery first for resectable colorectal liver metastases: a cohort study.
Behrenbruch C; Prabhakaran S; Udayasiri D; Hollande F; Michael M; Hayes I; Heriot A; Knowles B; Thomson B
ANZ J Surg; 2021 Jun; 91(6):1196-1202. PubMed ID: 33543551
[TBL] [Abstract][Full Text] [Related]
40. Clinical analysis of ultrasound-guided radiofrequency ablation for recurrent colorectal liver metastases after hepatectomy.
Fan XX; Lv SY; Zhang MW; Dai XY; Zhao JP; Mao DF; Zhang Y
World J Surg Oncol; 2020 Apr; 18(1):76. PubMed ID: 32312256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
